Antioxidants and Redox Signaling,
Journal Year:
2016,
Volume and Issue:
26(8), P. 364 - 387
Published: Sept. 14, 2016
Alzheimer's
disease
(AD)
is
a
multifactorial
neurodegenerative
disorder
and
represents
one
of
the
most
disabling
conditions.
AD
shares
many
features
in
common
with
systemic
insulin
resistance
diseases,
suggesting
that
it
can
be
considered
as
metabolic
disease,
characterized
by
reduced
insulin-stimulated
growth
survival
signaling,
increased
oxidative
stress
(OS),
proinflammatory
cytokine
activation,
mitochondrial
dysfunction,
impaired
energy
metabolism,
altered
protein
homeostasis.
Recent
Advances:
Reduced
glucose
utilization
metabolism
have
been
associated
buildup
amyloid-β
peptide
hyperphosphorylated
tau,
OS,
accumulation
unfolded/misfolded
proteins.
Mammalian
target
rapamycin
(mTOR),
which
aberrantly
activated
since
early
stages,
plays
key
role
during
neurodegeneration
by,
on
side,
inhibiting
signaling
negative
feedback
mechanism
and,
other
regulating
homeostasis
(synthesis/clearance).It
likely
concomitant
mutual
alterations
metabolism-mTOR
signaling-protein
might
represent
self-sustaining
triangle
harmful
events
trigger
degeneration
death
neurons
development
progression
AD.
Intriguingly,
cross-talk
between
components
such
death,
beyond
altering
redox
neuron,
further
exacerbated
levels
OS
impair
pathways
involved.
Redox
proteomic
studies
human
samples
animal
models
AD-like
dementia
led
to
identification
oxidatively
modified
composing
therefore
revealing
crucial
fueling
this
aberrant
vicious
cycle.The
compounds
able
restore
function
targeted
damage
valuable
therapeutic
approach
slow
or
delay
Antioxid.
Signal.
26,
364-387.
Frontiers in Aging Neuroscience,
Journal Year:
2020,
Volume and Issue:
11
Published: Jan. 10, 2020
Alzheimer's
disease
(AD)
is
one
of
the
incurable
neurodegenerative
diseases
characterised
by
accumulation
amyloid-beta
(plaques)
and
tau
hyperphosphorylation
(neurofibrillary
tangles)
in
brain
followed
neuronal
death,
cognitive
decline
memory
loss.
The
high
prevalence
AD
developed
world
has
become
a
major
public
health
challenge
associated
with
social
economic
burden
on
individuals
society.
Due
to
limited
options
early
diagnosis
exact
pathophysiology
AD,
finding
effective
therapeutic
strategies
great
challenge.
Several
possible
risk
factors
pathology
have
been
identified;
however
their
conclusive
role
still
unknown.
Recent
clinical
trials
drugs
targeting
are
failing
any
cure
for
pathology.
Therefore
preventive
should
be
reduce
exponential
increase
dementia,
especially
AD.
Although
search
new
targets
scientific
community,
lifestyle
interventions
nutraceuticals
prevention
many
metabolic
highly
appreciated
literature.
In
this
article,
we
summarised
molecular
mechanisms
involved
ameliorative
action
nutritional
including
diet,
exercise,
calorie
restrictions,
various
bioactive
compounds
dementia.
This
article
will
provide
insights
into
non-pharmacologic
modulation
pathology,
which
may
offer
benefit
improving
quality
life
reducing
incident
PubMed,
Journal Year:
2018,
Volume and Issue:
89(2), P. 276 - 290
Published: June 7, 2018
Cognitive
impairment
results
from
a
complex
interplay
of
many
factors.
The
most
important
independent
predictor
cognitive
decline
is
age
but
other
contributing
factors
include
demographic,
genetic,
socio-economic,
and
environmental
parameters,
including
nutrition.
number
persons
with
dementia
will
increase
in
the
next
decades
parallel
aging
world
population.
Effective
pharmaceutical
treatments
for
age-related
are
lacking,
emphasizing
importance
prevention
strategies.
There
extensive
evidence
supporting
relationship
between
diet
functions.
Thus,
nutritional
approaches
to
prevent
or
slow
could
have
remarkable
public
health
impact.
Several
dietary
components
supplements
been
examined
relation
their
association
development
decline.
A
studies
role
patterns
on
late-life
cognition,
accumulating
that
combinations
foods
nutrients
may
act
synergistically
provide
stronger
benefit
than
those
conferred
by
individual
components.
Higher
adherence
Mediterranean
pattern
has
associated
decreased
incident
AD.
Another
neuroprotective
actions
Dietary
Approach
Stop
Hypertension
(DASH).
combination
these
two
slower
rates
significant
reduction
This
review
evaluates
effects
some
components,
supplements,
as
neuroprotective,
potential
delay
onset
dementia.
Nutritional Neuroscience,
Journal Year:
2017,
Volume and Issue:
21(10), P. 695 - 714
Published: July 7, 2017
Polyunsaturated
fatty
acids
(PUFAs)
are
lipid
derivatives
of
omega-3
(docosahexaenoic
acid,
DHA,
and
eicosapentaenoic
EPA)
or
omega-6
(arachidonic
ARA)
synthesized
from
membrane
phospholipids
used
as
a
precursor
for
endocannabinoids
(ECs).
They
mediate
significant
effects
in
the
fine-tune
adjustment
body
homeostasis.
Phyto-
synthetic
cannabinoids
also
rule
daily
life
billions
worldwide,
they
involved
obesity,
depression
drug
addiction.
Consequently,
there
is
growing
interest
to
reveal
novel
active
compounds
this
field.
Cloning
cannabinoid
receptors
90s
identification
endogenous
mediators
arachidonylethanolamide
(anandamide,
AEA)
2-arachidonyglycerol
(2-AG),
led
characterization
endocannabinoid
system
(ECS),
together
with
their
metabolizing
enzymes
transporters.
Today,
ECS
known
be
diverse
functions
such
appetite
control,
food
intake,
energy
balance,
neuroprotection,
neurodegenerative
diseases,
stroke,
mood
disorders,
emesis,
modulation
pain,
inflammatory
responses,
well
cancer
therapy.
Western
diet
restriction
micronutrients
acids,
could
related
altered
production
pro-inflammatory
(e.g.
eicosanoids)
ECs,
contributing
progression
cardiovascular
diabetes,
impairing
conditions,
Alzheimer'
s
disease.
Here
we
review
how
diets
based
PUFAs
might
linked
maintenance
central
peripheral
metabolism,
brain
plasticity,
memory
learning,
blood
flow,
genesis
neural
cells.
Antioxidants and Redox Signaling,
Journal Year:
2016,
Volume and Issue:
26(8), P. 364 - 387
Published: Sept. 14, 2016
Alzheimer's
disease
(AD)
is
a
multifactorial
neurodegenerative
disorder
and
represents
one
of
the
most
disabling
conditions.
AD
shares
many
features
in
common
with
systemic
insulin
resistance
diseases,
suggesting
that
it
can
be
considered
as
metabolic
disease,
characterized
by
reduced
insulin-stimulated
growth
survival
signaling,
increased
oxidative
stress
(OS),
proinflammatory
cytokine
activation,
mitochondrial
dysfunction,
impaired
energy
metabolism,
altered
protein
homeostasis.
Recent
Advances:
Reduced
glucose
utilization
metabolism
have
been
associated
buildup
amyloid-β
peptide
hyperphosphorylated
tau,
OS,
accumulation
unfolded/misfolded
proteins.
Mammalian
target
rapamycin
(mTOR),
which
aberrantly
activated
since
early
stages,
plays
key
role
during
neurodegeneration
by,
on
side,
inhibiting
signaling
negative
feedback
mechanism
and,
other
regulating
homeostasis
(synthesis/clearance).It
likely
concomitant
mutual
alterations
metabolism-mTOR
signaling-protein
might
represent
self-sustaining
triangle
harmful
events
trigger
degeneration
death
neurons
development
progression
AD.
Intriguingly,
cross-talk
between
components
such
death,
beyond
altering
redox
neuron,
further
exacerbated
levels
OS
impair
pathways
involved.
Redox
proteomic
studies
human
samples
animal
models
AD-like
dementia
led
to
identification
oxidatively
modified
composing
therefore
revealing
crucial
fueling
this
aberrant
vicious
cycle.The
compounds
able
restore
function
targeted
damage
valuable
therapeutic
approach
slow
or
delay
Antioxid.
Signal.
26,
364-387.